VBS.AX
Price:
$0.115
Market Cap:
$6.14M
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. ...[Read more]
Industry
Biotechnology
IPO Date
2016-02-22
Stock Exchange
ASX
Ticker
VBS.AX
According to Vectus Biosystems Limited’s latest financial reports and current stock price. The company's current ROE is -2425.76%. This represents a change of 7.00% compared to the average of -34.17% of the last 4 quarters.
The mean historical ROE of Vectus Biosystems Limited over the last ten years is -247.78%. The current -2425.76% ROE has changed 879.01% with respect to the historical average. Over the past ten years (40 quarters), VBS.AX's ROE was at its highest in in the June 2025 quarter at 263.93%. The ROE was at its lowest in in the June 2017 quarter at -1925.26%.
Average
-247.78%
Median
43.72%
Minimum
-3255.11%
Maximum
692.56%
Discovering the peaks and valleys of Vectus Biosystems Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.70%
Maximum Annual ROE = 692.56%
Minimum Annual Increase = -540.27%
Minimum Annual ROE = -3255.11%
| Year | ROE | Change |
|---|---|---|
| 2025 | 692.56% | -540.27% |
| 2024 | -157.30% | 60.71% |
| 2023 | -97.88% | -208.36% |
| 2022 | 90.33% | -32.18% |
| 2021 | 133.18% | 198.28% |
| 2020 | 44.65% | 4.32% |
| 2019 | 42.80% | -62.68% |
| 2018 | 114.66% | -103.52% |
| 2017 | -3255.11% | 3.70% |
| 2016 | -85.65% | 480.29% |
The current ROE of Vectus Biosystems Limited (VBS.AX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
145.79%
5-year avg
132.18%
10-year avg
-247.78%
Vectus Biosystems Limited’s ROE is greater than Bio-Gene Technology Limited (-137.10%), less than Invex Therapeutics Ltd (-8.98%), less than Adherium Limited (757.14%), greater than Biotron Limited (-63.03%), greater than Acrux Limited (-268.28%), greater than Cann Group Limited (-1259.94%), greater than Invion Limited (-82.39%), less than InhaleRx Limited (296.01%), less than HITIQ Limited (226.39%), greater than Memphasys Limited (-86.37%),
| Company | ROE | Market cap |
|---|---|---|
| -137.10% | $7.63M | |
| -8.98% | $8.64M | |
| 757.14% | $7.71M | |
| -63.03% | $3.32M | |
| -268.28% | $6.16M | |
| -1259.94% | $6.33M | |
| -82.39% | $6.85M | |
| 296.01% | $5.64M | |
| 226.39% | $8.92M | |
| -86.37% | $12.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vectus Biosystems Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vectus Biosystems Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vectus Biosystems Limited's ROE?
How is the ROE calculated for Vectus Biosystems Limited (VBS.AX)?
What is the highest ROE for Vectus Biosystems Limited (VBS.AX)?
What is the 3-year average ROE for Vectus Biosystems Limited (VBS.AX)?
What is the 5-year average ROE for Vectus Biosystems Limited (VBS.AX)?
How does the current ROE for Vectus Biosystems Limited (VBS.AX) compare to its historical average?